| 1. |
Evaluating quality of care: how does the VA measure up? |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 454,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 2. |
Drug therapy + standard treatment adds value in prostate cancer? |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 454,
2004,
Page 3-3
&NA;,
Preview
|
|
摘要:
Prostate cancer is a prevalent and costly disease in the US, and the most common cancer among men. Non-surgical therapy frequently consists of androgen deprivation therapy (ADT) or radiation treatment combined with hormonal therapy. A study conducted in the US and presented at the 9th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) [Arlington, Virginia, US; May 2004] revealed that the addition of hormonal therapy to a regimen of radiation treatment was cost effective in patients with locally-advanced prostate cancer.1A second US-based study presented at the conference contends that although the risk of osteoporotic fracture associated with ADT could be reduced by the addition of bisphosphonate therapy, the extra benefit may not be worth the additional cost.2
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 3. |
Using medicines to manage elderly nursing-home residents is a"form of abuse", |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 454,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 4. |
Nondrug treatment for female sexual dysfunction costly in the UK |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 454,
2004,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 5. |
TEE-guided cardioversion worth the extra cost? |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 454,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 6. |
Self-management educational programme worth it in diabetes |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 454,
2004,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 7. |
Paediatric oncology programme improves outcomes in ALL |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 454,
2004,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 8. |
US costs for arthritis and other rheumatic disorders updated |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 454,
2004,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 9. |
QOL improves with additional SRL 172 in NSCLC |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 454,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 10. |
Free antiretrovirals for HIV/AIDS patients in African countries |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 454,
2004,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
